Analyst Research

Report Title Price
Provider : Reuters Investment Profile
Provider : Thomson Reuters Stock Report
Provider : Wright Reports
Provider : Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Zhongyuan Union Stem Cell Bioengineering Co to set up joint venture

Thursday, 24 Jul 2014 08:00pm EDT 

Zhongyuan Union Stem Cell Bioengineering Co:To set up a joint venture in Tianjin, with an individual, Li Tongen.The joint venture will be mainly engaged in clinical laboratory medicine business, technological development, sales of laboratory instruments and meters, with a registration capital of 50 million yuan.The company will hold a 95 pct stake in the joint venture. 

Company Quote